Eden Research Plc commercial partner receives full authorisation for Cedroz in Mexico

  • Dec 19, 2019 GMT
  • Team Kalkine

Eden Research Plc (LON: EDEN) has announced that its commercial partner, Eastman Chemical Company, has received full authorisation for Eden's nematicide formulation, marketed as Cedroz™ by Eastman, in Mexico.

  • The company has reported that with this authorisation access has now been gained into the all-important US agricultural import market. It is first for the company’s developed products in Mexico, giving it a foothold into the Americas.
  • Cedroz an innovative and natural solution, offers growers huge benefits by offering high levels of efficacy against nematodes.
  • On 19th December 2019, at the time of writing, GMT 08:03 AM, EDEN shares were trading at GBX 8.75, up by 0.95 points or 12.18% against the previous day closing price.

With Bank of England reducing the interest rates to a historic low level, the spotlight is back on diverse investment opportunities. 

Amidst this, are you getting worried about these falling interest rates and wondering where to put your money?

Well! Team Kalkine has a solution for you. You still can earn a relatively stable income by putting money in the dividend-paying stocks.

We think it is the perfect time when you should start accumulating selective dividend stocks to beat the low-interest rates, while we provide a tailored offering in view of valuable stock opportunities and any dividend cut backs to be considered amid scenarios including a prolonged market meltdown.

To know more about these dividend stocks, click here

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK